Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies
- PMID: 2184504
- DOI: 10.1093/clinids/12.supplement_3.s272
Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies
Abstract
In vitro studies of fluconazole have demonstrated that test results can be influenced by several test conditions, including medium composition, pH, and size of the starting fungal inoculum. In studies with Candida albicans, a few isolates have been identified that are markedly more resistant than other strains of the same species; in several in vivo studies of experimental infections, the more resistant isolates have caused infections less susceptible to fluconazole treatment. These findings corroborate a relation between in vitro and in vivo results. With further work it should be possible to define standard methods for use by clinical laboratories in determining fungal susceptibility to fluconazole.
Similar articles
-
[Multicenter study of fungemia due to yeasts in Argentina].Rev Argent Microbiol. 2005 Oct-Dec;37(4):189-95. Rev Argent Microbiol. 2005. PMID: 16502638 Spanish.
-
Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?Antimicrob Agents Chemother. 1995 Oct;39(10):2197-200. doi: 10.1128/AAC.39.10.2197. Antimicrob Agents Chemother. 1995. PMID: 8619566 Free PMC article.
-
In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.J Antimicrob Chemother. 2003 May;51(5):1223-9. doi: 10.1093/jac/dkg202. Epub 2003 Mar 28. J Antimicrob Chemother. 2003. PMID: 12668571
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Antifungal drug resistance in pathogenic fungi.Med Mycol. 1998;36 Suppl 1:119-28. Med Mycol. 1998. PMID: 9988500 Review.
Cited by
-
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.J Clin Microbiol. 1992 Dec;30(12):3138-45. doi: 10.1128/jcm.30.12.3138-3145.1992. J Clin Microbiol. 1992. PMID: 1452697 Free PMC article.
-
Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry.Antimicrob Agents Chemother. 1998 Oct;42(10):2534-41. doi: 10.1128/AAC.42.10.2534. Antimicrob Agents Chemother. 1998. PMID: 9756752 Free PMC article.
-
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.Eur J Clin Microbiol Infect Dis. 1997 May;16(5):337-45. doi: 10.1007/BF01726360. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9228472 Clinical Trial.
-
Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.Eur J Epidemiol. 1995 Apr;11(2):243-4. doi: 10.1007/BF01719497. Eur J Epidemiol. 1995. PMID: 7672085
-
Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice.Antimicrob Agents Chemother. 2002 Oct;46(10):3175-9. doi: 10.1128/AAC.46.10.3175-3179.2002. Antimicrob Agents Chemother. 2002. PMID: 12234841 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical